期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
倍他乐克早期强化治疗对急性心梗患者压力和化学反射敏感性的影响 被引量:1
1
作者 卢青 丁世芳 +2 位作者 马大波 蒋桔泉 陈志楠 《华南国防医学杂志》 CAS 2006年第3期9-13,共5页
目的研究在急性心肌梗死(AMI)发作的早期,倍他乐克强化治疗对病人压力反射敏感性(BRS)和化学反射敏感性 (ChRS)的影响。方法采用随机、双盲、安慰剂对照的方案,将76例急性心梗后病人随机分为倍他乐克组(40例)和安慰剂组(36 例),在急性... 目的研究在急性心肌梗死(AMI)发作的早期,倍他乐克强化治疗对病人压力反射敏感性(BRS)和化学反射敏感性 (ChRS)的影响。方法采用随机、双盲、安慰剂对照的方案,将76例急性心梗后病人随机分为倍他乐克组(40例)和安慰剂组(36 例),在急性心梗症状出现后24小时内即给予倍他乐克5mg或安慰剂iv,每3分钟一次,共3次,继之以倍他乐克50mg或安慰剂口服,每6小时一次,共2天,再继以200mg口服一天一次,直至病人出院。在入院后第5天及出院时分别测定BRS和ChRS。结果患者出院时,倍他乐克组与对照组BRS、ChRS较用药第五天均有显著增加。用药第5天,倍他乐克组与对照组间BRS、 ChRS值均无显著性差异;但在出院时,倍他乐克组BRS,ChRS值较对照组显著增加。不同心梗部位的亚组病人间BRS、ChRS 值差异无显著性。结论所有患者均可耐受大剂量倍他乐克的冲击式治疗。不同心梗部位病人均可从倍他乐克治疗中同样获益,早期应用倍他乐克可显著改善急性心梗后病人BRS、ChRS值,恢复其心自主神经功能平衡,可能是其减少AMI后急性缺血性事件和恶性心律失常事件的机制之一。 展开更多
关键词 急性心肌梗塞 压力反射敏感性 倍他乐克
暂未订购
普拉固早期强化治疗对急性心肌梗死患者压力和化学反射敏感性的影响
2
作者 卢青 丁世芳 马大波 《中国心脏起搏与心电生理杂志》 2005年第2期117-120,共4页
研究在急性心肌梗死(AMI)发作的早期,普拉固强化治疗对患者压力反射敏感性(BRS)和化学反射敏感性(ChRS)的影响。采用随机、单盲、空白对照方法,共入选84例AMI患者,均在入院后24h内随机分配至对照组(n=28),传统治疗组(普拉固组20mg/d,n=2... 研究在急性心肌梗死(AMI)发作的早期,普拉固强化治疗对患者压力反射敏感性(BRS)和化学反射敏感性(ChRS)的影响。采用随机、单盲、空白对照方法,共入选84例AMI患者,均在入院后24h内随机分配至对照组(n=28),传统治疗组(普拉固组20mg/d,n=28),强化治疗组(普拉固组40mg/d,n=28)。3组主要基本资料具有可比性。分别在入院时、用药后4周检测血脂水平、BRS值、ChRS值及所有不良反应。结果:普拉固组20mg/d和40mg/d治疗4周后的患者较治疗前血脂指标均有明显改善;与对照组相比,2治疗组治疗后的血脂水平有显著改善(P<0.05);2治疗组间差异无显著性。4周后3组BRS值、ChRS值较入院时均有明显改善;与对照组相比,2治疗组治疗后的BRS值、ChRS值均有显著改善(7.34±2.26,6.87±0.53vs5.66±1.34;7.83±3.36,6.38±1.25vs5.28±1.12;P均<0.01);与传统治疗组相比,强化治疗组治疗后BRS值、ChRS值的差异亦有显著性。结论:普拉固早期强化干预能改善AMI的BRS、ChRS值,且具有剂量依赖性。 展开更多
关键词 心血管病学 急性心肌梗死 压力反射敏感性 化学反射敏感性 普拉固
暂未订购
Peripheral reflex feedbacks in chronic heart failure:Is it time for a direct treatment?
3
作者 Alberto Giannoni Gianluca Mirizzi +2 位作者 Alberto Aimo Michele Emdin Claudio Passino 《World Journal of Cardiology》 CAS 2015年第12期824-828,共5页
Despite repeated attempts to develop a unifying hypothesis that explains the clinical syndrome of heart failure(HF),no single conceptual paradigm for HF has withstood the test of time. The last model that has been dev... Despite repeated attempts to develop a unifying hypothesis that explains the clinical syndrome of heart failure(HF),no single conceptual paradigm for HF has withstood the test of time. The last model that has been developed,the neurohormonal model,has the great virtue of highlighting the role of the heart as an endocrine organ,as well as to shed some light on the key role on HF progression of neurohormones and peripheral organs and tissues beyond the heart itself. However,while survival in clinical trials based on neurohormonal antagonist drugs has improved,HF currently remains a lethal condition. At the borders of the neurohormonal model of HF,a partially unexplored path trough the maze of HF pathophysiology is represented by the feedback systems. There are several evidences,from both animal studies and humans reports,that the deregulation of baro-,ergo- and chemo-reflexes in HF patients elicits autonomic imbalance associated with parasympathetic withdrawal and increased adrenergic drive to the heart,thus fundamentally contributing to the evolution of the disease. Hence,on top of guidelinerecommended medical therapy,mainly based on neurohormonal antagonisms,all visceral feedbacks have been recently considered in HF patients as additional potential therapeutic targets. 展开更多
关键词 BAROREFLEX chemoreflex Ergoreflex Heart failure SYMPATHETIC system NEUROHORMONES
暂未订购
Modeling of Mechanisms Providing the Overall Control of Human Circulation
4
作者 Grygoryan R.D. 《Advances in Human Physiology Research》 2022年第1期5-21,共17页
Multiple humoral and nervous mechanisms,each influencing the cardiovascular system(CVS)with its specific dynamics and power,had been evolutionarily saved both in animals and in human organisms.Most of such mechanisms ... Multiple humoral and nervous mechanisms,each influencing the cardiovascular system(CVS)with its specific dynamics and power,had been evolutionarily saved both in animals and in human organisms.Most of such mechanisms are considered to be controllers of CVS’s function,but there is no concept clearly explaining the interaction of global and local controllers in intact human organisms under physiological or pathological conditions.Methodological and ethical constraints create practically insuperable obstacles while experiments on animals mainly concern artificial situations with certain switched-of mechanisms.Currently,mathematical modeling and computer simulations provide the most promising way for expanding and deepening our understanding of regulators’interactions.As most of CVS’s models describe only partial control mechanisms,a special model(SM)capable of simulating every combination of control mechanisms is encouraged.This paper has three goals:i)to argue the uncial modeling concept and its physiological basis,ii)to describe SM,and iii)to give basic information about SM’s test research.SM describes human hemodynamics,which is under influence of arterial baroreceptor reflexes,peripheral chemoreceptor reflexes,central(cRAS)and local(lRAS)renin-angiotensin systems,local ischemia,and autoregulation of total brain flow.SM,performed in form of special software(SS),is tested under specific endogenous and/or exogenous alterations.The physiologist using SS can easily construct the desirable configuration of regulator mechanisms,their actual state,and scenarios of computer experiments.Tests illustrated the adequateness of SM,are the first step of SM’s research.Nuances of the interaction of modeled regulator mechanisms have to be illustrated in special publications. 展开更多
关键词 Arterial pressure ANGIOTENSIN BAROREFLEX chemoreflex HYPERTENSION Renin-angiotensin systems ISCHEMIA Simulation
暂未订购
缺氧诱导因子-1α与阻塞性睡眠呼吸暂停相关高血压的研究进展 被引量:1
5
作者 黎宁 吴峰 胡涛 《实用临床医药杂志》 CAS 2023年第7期138-142,共5页
阻塞性睡眠呼吸暂停(OSA)是一种呼吸障碍性疾病,与顽固性高血压密切相关。OSA可引起缺氧诱导因子-1α(HIF-1α)的水平升高,并且间歇性低氧(IH)会导致HIF-α亚型失调,与OSA相关高血压相关。本研究探讨IH引起HIF-α亚型失调导致活性氧(ROS... 阻塞性睡眠呼吸暂停(OSA)是一种呼吸障碍性疾病,与顽固性高血压密切相关。OSA可引起缺氧诱导因子-1α(HIF-1α)的水平升高,并且间歇性低氧(IH)会导致HIF-α亚型失调,与OSA相关高血压相关。本研究探讨IH引起HIF-α亚型失调导致活性氧(ROS)的生成增加,进而激活化学反射、减弱压力反射并且导致内皮功能障碍影响血压调节的机制,展望HIF-1α相关抑制性药物用于治疗OSA相关高血压的前景。 展开更多
关键词 缺氧诱导因子-1Α 阻塞性睡眠呼吸暂停 高血压 活性氧 化学反射 压力反射 时钟基因
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部